通达动力（002576.SZ）12月4日在投资者互动平台表示，您好，截至目前，公司共取得187项授权专 利。通达动力全资子公司南通通达矽钢冲压科技有限公司于2021年获评国家级专精特新"小巨人"企业。 （文章来源：每日经济新闻） 每经AI快讯，有投资者在投资者互动平台提问：公司公司拥有多少项授权专利？是国家级专精特新＂ 小巨人＂企业吗？ ...

今年前10个月，天津AEO企业进出口值同比增15% 广告等商务合作，请点击这里 本文为转载内容，授权事宜请联系原著作权人 中新经纬版权所有，未经书面授权，任何单位及个人不得转载、摘编或以其它方式使用。 关注中新经纬微信公众号(微信搜索"中新经纬"或"jwview")，看更多精彩财经资讯。 据介绍，该企业为光伏支架生产企业，今年年初，在了解到企业申请成为AEO企业的意愿后，静海海 关联合东丽海关认证中心第一时间开展认证培育工作，从内部控制、贸易安全等方面为企业进行系 统"体检"，助力企业顺利通过AEO认证。 为助力天津市更多外贸企业享受到AEO带来的政策红利，天津海关紧扣地方产业布局，以AEO认证为 抓手，围绕新质生产力、专精特新等生产型企业建立AEO重点企业培育库，一对一开展信用培育，助 推企业信用升级、管理增效，定期进行信用评估、跟踪问效，及时给予指导和帮助，推送适用于企业的 最新政策，不断提升企业信用管理水平，为AEO企业开拓国际市场带来便利。(完) 来源：中国新闻网 编辑：万可义 中新网天津12月4日电 (记者 王君妍)记者4日从天津海关获悉，据海关统计，今年前10个月，天津市 AEO企业进出口值为27 ...

Core Viewpoint - The company, Shandong Bailong Chuangyuan Biotechnology Co., Ltd., is experiencing a decline in stock price while benefiting from its unique product offerings and strategic investments, particularly in the context of the depreciating RMB and its recognition as a "specialized and innovative" enterprise. Group 1: Company Overview - The company specializes in the research, production, and sales of prebiotics, dietary fiber products, and healthy sweeteners, with a revenue composition of 54.15% from dietary fiber, 28.00% from prebiotics, 13.57% from healthy sweeteners, and 3.91% from other products [8] - As of November 30, the company had 10,900 shareholders, a decrease of 18.48% from the previous period, with an average of 38,364 circulating shares per shareholder, an increase of 22.67% [8] - The company achieved a revenue of 969 million yuan in the first nine months of 2025, representing a year-on-year growth of 18.10%, and a net profit of 265 million yuan, up 44.93% year-on-year [8] Group 2: Market Position and Financials - The company holds a 5.14% stake in Shandong Yucheng Rural Commercial Bank, which may provide additional financial stability [3] - The overseas revenue accounts for 60.62% of total revenue, benefiting from the depreciation of the RMB [4] - The company has distributed a total of 183 million yuan in dividends since its A-share listing, with 172 million yuan distributed over the past three years [9] Group 3: Investment Highlights - The company produces allulose, a rare monosaccharide that serves as a low-calorie alternative to sucrose, making it ideal for individuals with obesity and diabetes [2] - The company has been recognized as a "specialized and innovative" enterprise, which is a prestigious title for small and medium-sized enterprises in China, indicating strong market focus and innovation capabilities [4] - The stock has seen a recent decline of 2.01% with a trading volume of 48.91 million yuan and a market capitalization of 8.61 billion yuan [1]

来源：新浪证券-红岸工作室 12月4日，汇成股份涨3.89%，成交额6.37亿元，换手率5.04%，总市值128.35亿元。 异动分析 存储芯片+先进封装+芯片概念+人民币贬值受益+专精特新 1、2025年10月14日公司，合肥新汇成微电子股份有限公司举办特定对象调研活动，向舟资本、兴全基 金、平安资管等多家机构投资者披露重磅布局：公司通过直接与间接投资相结合，拿下合肥鑫丰科技有 限公司（简称 "鑫丰科技"）27.5445% 股权，并与鑫丰科技股东华东科技（苏州）有限公司（简称 "华 东科技"）达成战略合作，共同拓展 3D DRAM 等存储芯片封测业务，瞄准 AI 基建时代下存储芯片的爆 发式需求。 2、据2023年2月投资者关系活动记录表： Chiplet先进封装技术是凸块制造、Fan-out、3D、SiP等高端先 进封装技术的集合，公司掌握的凸块制造技术是Chiplet的基础之一。在研发端，公司将以客户需求为导 向，基于凸块制造技术，纵向拓展技术边界，积极布局Fan-out、2.5D/3D、SiP等高端先进封装技术。 3、合肥新汇成微电子股份有限公司的主营业务是集成电路高端先进封装测试服务。公司的主要产品 ...

来源：新浪证券-红岸工作室 2、根据2024年年报，公司海外营收占比为82.39%，受益于人民币贬值。 异动分析 共同富裕示范区+人民币贬值受益+专精特新+智能家居+3D打印 3、专精特新"小巨人"企业是全国中小企业评定工作中最高等级、最具权威的荣誉称号，是指专注于细 分市场、创新能力强、市场占有率高、掌握关键核心技术、质量效益优的排头兵企业，对于提升中小企 业自身的竞争力，以及提升产业链、供应链稳定性和竞争力具有重大意义。公司已入选工信部国家级专 精特新小巨人企业名单。 4、浙江万得凯流体设备科技股份有限公司主营业务为水暖器材、阀门、管件、建筑金属配件、智能家 居及环保节能控制系统等相关产品的研发、制造、销售与服务。 12月4日，万得凯跌0.88%，成交额1649.73万元，换手率2.29%，总市值28.33亿元。 5、2024年7月3日互动易：公司3D打印业务主要是为航天航空客户提供非金属打印产品，目前尚处于研 发送样阶段，还未产生实质性销售。 (免责声明：分析内容来源于互联网，不构成投资建议，请投资者根据不同行情独立判断) 资金分析 1、公司位于浙江省台州市玉环市龙溪镇东港村渔业，从事水暖器材的设计、开 ...

Core Viewpoint - The company, Zhejiang Kaichuang Electric Co., Ltd., is experiencing growth in its electric tool sales and has significant potential for expansion in the lithium battery sector, benefiting from currency depreciation and recognition as a "specialized and innovative" enterprise [2][6]. Group 1: Company Performance - The company developed 20 new lithium battery products in 2023, gaining recognition from clients such as Bosch and Harbor Freight Tools, with lithium products currently accounting for less than 10% of total sales, indicating room for growth [2]. - For the fiscal year 2024, the company reported an overseas revenue share of 91.85%, benefiting from the depreciation of the Chinese yuan [2]. - The company has been recognized as a "national-level specialized and innovative" enterprise, which enhances its competitiveness and stability within the supply chain [2]. - In the first nine months of 2025, the company achieved a revenue of 490 million yuan, a decrease of 12.96% year-on-year, and reported a net profit loss of 10.46 million yuan, a decline of 119.10% [6]. Group 2: Market Activity - On December 4, the company's stock rose by 2.20%, with a trading volume of 32.65 million yuan and a turnover rate of 1.18%, bringing the total market capitalization to 6.033 billion yuan [1]. - The stock's average trading cost is 59.92 yuan, with the current price fluctuating between resistance at 61.50 yuan and support at 53.82 yuan, suggesting potential for range trading [5]. - The main capital inflow for the day was negative at 374,400 yuan, indicating a reduction in main capital over the past two days [3][4].

Core Viewpoint - The company Meai (China) Environmental Technology Co., Ltd. is a leading domestic brand in the air purification and environmental governance sector, focusing on high-efficiency air purification products and solutions for semiconductor manufacturing [2][3]. Company Overview - Meai specializes in the research, production, and sales of air purification products and atmospheric environmental governance products, with its main products including fan filter units, filters, and air purification equipment [3][7]. - The company was recognized as a national-level "specialized, refined, and innovative" small giant by the end of 2021, establishing itself as a leader in cleanroom equipment for the semiconductor industry in China [3][7]. - As of September 30, 2025, Meai achieved a revenue of 1.486 billion yuan, representing a year-on-year growth of 23.64%, while the net profit attributable to shareholders was 141 million yuan, a decrease of 5.17% year-on-year [7][8]. Market Position and Products - The company has developed the first domestic 28nm lithography equipment and provides products that meet the highest international cleanliness standards (ISO Class 1) for semiconductor manufacturing [2]. - Meai is a qualified supplier for international semiconductor manufacturers such as Intel and ST Microelectronics, indicating its competitive position in the market [2]. - The company has long supplied products to SMIC (Semiconductor Manufacturing International Corporation) to meet the air cleanliness requirements for advanced manufacturing processes, including 14nm and 28nm nodes [2][3]. Financial Performance - The company's stock experienced a decline of 1.05% on December 4, with a trading volume of 56.1534 million yuan and a market capitalization of 6.249 billion yuan [1]. - The average trading cost of the stock is 47.59 yuan, with recent trading activity indicating a lack of strong accumulation or distribution trends [5][6]. Shareholder Information - As of September 30, 2025, the number of shareholders increased by 36.07% to 5,817, while the average circulating shares per person decreased by 26.51% [7]. - The company has distributed a total of 80.64 million yuan in dividends since its A-share listing [9].

Core Viewpoint - The company, Qindao Haitai New Light Technology Co., Ltd., is focused on integrating optical technology with cutting-edge medical device applications, particularly in high-performance endoscope products, and has a strong vertical integration capability in the industry [2][3]. Company Overview - Qindao Haitai New Light was established on June 11, 2003, and went public on February 26, 2021. Its main business includes the research, development, production, and sales of medical endoscope devices and optical products [7]. - The revenue composition of the company is as follows: medical endoscope devices 64.86%, optical products 21.63%, maintenance services 13.09%, and leasing 0.42% [7]. Financial Performance - For the period from January to September 2025, the company achieved a revenue of 448 million yuan, representing a year-on-year growth of 40.47%. The net profit attributable to the parent company was 136 million yuan, with a year-on-year increase of 40.03% [7]. - The company has distributed a total of 277 million yuan in dividends since its A-share listing, with 207 million yuan distributed over the past three years [8]. Market Position and Recognition - The company has been recognized as a "specialized, refined, distinctive, and innovative" small giant enterprise, which is a prestigious title in China for small and medium-sized enterprises that excel in niche markets and possess strong innovation capabilities [3]. - As of the latest report, 69.12% of the company's revenue comes from overseas markets, benefiting from the depreciation of the Chinese yuan [3]. Stock Performance - On December 4, the stock price of Haitai New Light decreased by 0.04%, with a trading volume of 27.27 million yuan and a turnover rate of 0.50%. The total market capitalization is 5.45 billion yuan [1]. - The average trading cost of the stock is 46.62 yuan, with recent buying activity observed, although the buying pressure is not strong. The stock is currently trading between a resistance level of 46.80 yuan and a support level of 42.48 yuan [6].

Investment Rating - The report maintains an "Outperform" rating for the industry [5] Core Insights - The North Exchange 50 index experienced a significant decline of 12.32% in November 2025, with the index closing at 1,387.70 points [31] - The total number of listed companies on the North Exchange reached 285, with a total market capitalization of 827.155 billion and a circulating market value of 507.712 billion, reflecting a decrease of 10.2% and 11.2% respectively [11][18] - The report highlights that all sectors within the North Exchange experienced declines, with the most significant drops in household appliances, transportation, communication, automotive, and non-ferrous metals [35] Market Overview - The trading volume for November was 16.987 billion shares, with a total transaction value of 376.778 billion, marking a month-on-month increase of 9.9% in volume and 3.1% in value [18][21] - The average daily margin balance for the North Exchange in November was 7.789 billion, showing a month-on-month increase of 2.35% [22] Valuation Metrics - As of November 28, the North Exchange 50 index had a price-to-earnings ratio (PE-TTM) of 43.07, placing it at the 67.98th percentile over the past two years, while the price-to-book ratio (PB-MRQ) was 8.89, at the 75.21st percentile [24][27] - The dividend yield was reported at 0.78, corresponding to the 26.56th percentile over the same period [24] Industry Performance - The report indicates that the North Exchange's specialized and innovative index fell by 13.44% in November, with other major indices also experiencing declines, including the Sci-Tech 50 down 6.24% and the ChiNext index down 4.23% [31] - The report notes that the North Exchange's new listings included five companies: Danna Biological, Zhongcheng Consulting, Beikang Testing, Dapeng Industrial, and Nante Technology [11][3] Policy and Events - In November 2025, the Beijing Stock Exchange introduced a series of policies aimed at enhancing market vitality and solidifying institutional foundations, achieving progress in information disclosure, institutional behavior, new stock performance, and ongoing supervision [4]

Company Overview - Shengquan Group, established on January 24, 1994, is located in the Industrial Economic Development Zone of Diao Town, Zhangqiao District, Jinan City, Shandong Province. The company was listed on August 10, 2021. Its main business involves the research, production, and sales of synthetic resins and composite materials, as well as biomass chemical materials and related products [1]. Financial Performance - For the period from January to September 2025, Shengquan Group achieved operating revenue of 8.072 billion yuan, representing a year-on-year growth of 12.87%. The net profit attributable to shareholders was 760 million yuan, reflecting a year-on-year increase of 30.81% [2]. - Since its A-share listing, Shengquan Group has distributed a total of 1.29 billion yuan in dividends, with 942 million yuan distributed over the past three years [3]. Stock Performance - As of December 4, Shengquan Group's stock price was 26.06 yuan per share, with a market capitalization of 22.057 billion yuan. The stock has increased by 13.05% year-to-date but has seen a decline of 1.25% over the last five trading days, 4.05% over the last 20 days, and 16.63% over the last 60 days [1]. - The stock experienced a net outflow of 15.3843 million yuan in principal funds, with significant selling pressure observed in large orders [1]. Shareholder Structure - As of September 30, 2025, the number of shareholders for Shengquan Group reached 31,100, an increase of 15.57% from the previous period. The average number of circulating shares per shareholder decreased by 13.47% to 25,135 shares [2]. - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited is the second-largest shareholder, holding 34.131 million shares, an increase of 27.1574 million shares from the previous period. New shareholder Penghua Zhongzheng Fine Chemical Industry Theme ETF has entered the list as the seventh-largest shareholder with 10.1658 million shares [3].